Nebius Tanked This Month: A Resolute Wall Street Pro Expects 95% Gains Over The Next Twelve
Nebius shed nearly a quarter of its value in a single month despite explosive revenue growth, and one resolute Wall Street shop just raised its price target to a level that would require the stock to nearly double from here.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) trades at $212.19, while the average Wall Street price target sits at $290.71. That is roughly a 37% gap between where the stock is and where analysts think it should be within the next twelve months.
Nebius is a full-stack AI cloud infrastructure operator, renting GPU capacity to AI labs, hyperscalers, and enterprises. The company also owns TripleTen, Avride, Toloka, and an equity stake in ClickHouse. Wall Street has focused on Nebius as one of the few independent providers building multi-gigawatt capacity to serve the AI training and inference boom.
The gap matters because Arete Research, the Street-high shop on the name, sees room for close to a double. Its $415 price target, raised from $380 alongside a Buy/Outperform reiteration, implies roughly 96% upside from here. That is the number driving the headline.
September Reversed a Blistering Run
The stock has fallen 23.58% over the past month, sliding from $277.68 on August 14 to $212.19, including a 5.5% drop on the most recent trading day alone. The selloff has been sharp, though it follows an explosive run that still leaves the stock up 153.5% year to date.
The pullback is more profit-taking than fundamental breakage. Q2 2026 revenue came in at $582.3 million, up 454% year over year, beating the $574.65 million consensus. GAAP EPS of -$0.68 beat the -$0.8633 estimate. Investors instead appear focused on Nebius issuing 12.7 million ATM shares at an average $223.60, the $8.13 billion H1 capex bill, and rising customer concentration, with three customers making up 24%, 21%, and 14% of Q2 revenue. The neocloud group also sold off together, with peers falling roughly the same amount.
Analysts Anchor to Contracted Backlog
The bull case rests on backlog. Nebius carries $37.5 billion in remaining performance obligations and management cited $40 billion in contracted backlog on the Q2 call. Arete points to multi-year hyperscaler agreements with Microsoft and Meta, aggressive scaling past 1 GW of connected power, and high-margin unit economics as the pillars supporting its $415 target.
Management reiterated 2026 guidance of $3.0 billion to $3.4 billion in revenue, $7 billion to $9 billion in year-end ARR, and roughly 40% adjusted EBITDA margin. Q2 adjusted EBITDA reached $236 million at a 41% margin, and Nebius AI Cloud alone hit a 50% adjusted EBITDA margin. A Q2 capacity auction cleared at 15% above the highest price we ever charged before, per management, which analysts read as validation that Blackwell pricing is holding.
Coverage is thin but constructive. The consensus panel shows 1 Strong Buy, 2 Buy, and 2 Hold ratings, with no Sells. Recent EPS revisions have moved down as capex assumptions rise, yet the price target has climbed, an unusual combination that reflects analysts modeling steeper near-term losses on the way to a much larger 2027 revenue base. The Street sees the payoff as the pricing anchor.
Neoclouds Sold Off in Lockstep
Nebius did not fall alone. Its closest US-listed peers tumbled the same week on the same concerns about capex intensity and financing.
CoreWeave (NASDAQ:CRWV) trades at $82.98, down 21.17% over the past month. The average target of $144.46 implies roughly 74% upside. Analyst posture leans bullish, with 5 Strong Buy, 21 Buy, 10 Hold, 1 Sell, and 1 Strong Sell ratings on a much larger coverage list. Reddit sentiment on the name is very bearish over one week.
Applied Digital (NASDAQ:APLD) sits at $24.58, off 21.22% on the month. Its $74.23 average target implies roughly 202% upside, easily the largest gap in the group. Coverage skews bullish at 2 Strong Buy, 8 Buy, and 1 Hold, though APLD carries greater execution risk as a smaller developer leaning on CoreWeave as its anchor tenant.
Targets are model outputs. Still, the biggest implied upside sits at Applied Digital, followed by Nebius at Arete’s $415 mark, then CoreWeave. On the group’s average target, Nebius screens as the most balanced setup: massive backlog, positive EBITDA, and moderate consensus upside. All three names are riding the same data-center buildout, and we profiled seven of the picks-and-shovels suppliers powering it in a free report on AI infrastructure beyond the chipmakers.
What the Stock and the Targets Actually Say
Nebius trades at $212.19 against a consensus target of $290.71, drawn from 5 covering analysts. The implied upside to consensus is roughly 37%, and to Arete’s Street-high $415 is roughly 96%.
The stock is up 153.5% year to date and 134.7% over the trailing year. The S&P 500 is up 11.57% year to date and down 2% over the past month. Nebius has trounced the index in 2026 but underperformed it sharply over the past four weeks, which is what created the current gap to targets.
Valuation stays rich. The stock trades at a price-to-sales ratio of 42 on TTM revenue of $1.36 billion, and a forward P/E of 46. That is a growth multiple, and it requires the ARR ramp to land.
Where I Come Down on Nebius
The bull case on Nebius rests on management converting the $40 billion contracted backlog into 2027 revenue at the pricing shown in the Q2 auction, hitting the $7 billion to $9 billion year-end ARR band, and financing the buildout without a punishing round of dilution. That path gets analysts to $290 and gives Arete’s $415 a real shot.
The bear case builds if capex keeps outrunning revenue, if customer concentration turns into contract renegotiation leverage, or if the $8.5 billion convertible stack starts pressuring the equity as it converts. Any of those makes the current multiple hard to defend even with 454% revenue growth.
My lean is cautiously constructive. The fundamentals justify the bull case, the September drop looks like digestion of a monster run rather than a thesis break, and the Street has not blinked on targets. The 37% path to consensus looks reachable. The 96% path to Arete’s number requires everything to break right.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
